Cargando…
Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio
BACKGROUND: Serum free light chain assay (SFLCA) and κ/λ ratio, and protein electrophoretic methods are used in the diagnosis and monitoring of monoclonal gammopathies. METHODS: Results for serum free light chains, serum and urine protein electrophoreses and immunofixation electrophoreses in 468 pat...
Autor principal: | Singh, Gurmukh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127215/ https://www.ncbi.nlm.nih.gov/pubmed/27924175 http://dx.doi.org/10.14740/jocmr2802w |
Ejemplares similares
-
Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018) -
Free Light Chains κ and λ as New Biomarkers of Selected Diseases
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023) -
Adaption of human antibody λ and κ light chain architectures to CDR repertoires
por: van der Kant, Rob, et al.
Publicado: (2019) -
Tables of λ , k°, ∑± lifetimes and λ°, k° decay branching ratios
por: Glaser, D A, et al.
Publicado: (1958) -
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)